IPO - Benitec Biopharma Inc.

Form Type: 8-K

Filing Date: 2025-03-28

Corporate Action: Ipo

Type: New

Accession Number: 000119312525067232

Filing Summary: On March 25, 2025, Benitec Biopharma Inc. entered into an Underwriting Agreement for an underwritten offering of 1,143,000 shares of its common stock at $13.00 per share and pre-funded warrants for 300,000 shares at an exercise price of $0.0001 per share, priced at $12.999 per warrant. The company also finalized a Securities Purchase Agreement with Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd. for an aggregate of 900,000 shares of common stock at $13.00 per share in a registered direct offering. The closing of both offerings occurred on March 26, 2025. Following the offerings, the company had a total of 25,546,288 shares of common stock outstanding, alongside common warrants for 5,876,866 shares and pre-funded warrants for an aggregate of 15,270,807 shares.